Stem cell-based treatments for spinal cord injury

被引:15
作者
Wyatt, Lindsey A. [1 ,2 ,3 ,4 ]
Keirstead, Hans S. [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif Irvine, Reeve Irvine Res Ctr, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA
[3] Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92717 USA
[4] Univ Calif Irvine, Sch Med, Dept Neurol Surg, Irvine, CA 92717 USA
来源
FUNCTIONAL NEURAL TRANSPLANTATION III PRIMARY AND STEM CELL THERAPIES FOR BRAIN REPAIR, PT II | 2012年 / 201卷
关键词
stem cells; spinal cord injury; embryonic stem cells; oligodendrocyte progenitor cells; motor neuron progenitor cells; neural stem cell; hematopoietic stem cell; mesenchymal stem cell; MARROW STROMAL CELLS; CENTRAL-NERVOUS-SYSTEM; PROMOTE FUNCTIONAL RECOVERY; NEURAL PROGENITOR CELLS; BONE-MARROW; CLINICAL-TRIALS; ICCP PANEL; IN-VITRO; PRECURSOR CELLS; MOTOR-NEURONS;
D O I
10.1016/B978-0-444-59544-7.00012-3
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Cell replacement strategies hold great promise for the treatment of central nervous system injuries and degenerative diseases. The advancement of stem cell therapies has proven to be a viable therapeutic approach to limit secondary degeneration and restore neuronal circuitry at the site of injury. Cell replacement strategies confer phenotype-specific and neurotrophic benefits to the surrounding tissue; however, the mechanisms of transplant-mediated repair are unique to each transplant population. Here, we review stem cell-based therapies for spinal cord injury and disease, involving a number of stem cell derivates. We discuss the mechanisms by which each of these populations exert their affects and briefly discuss phenotype-specific cell replacement in these models.
引用
收藏
页码:233 / 252
页数:20
相关论文
共 123 条
[1]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]   Remyelination of the spinal cord following intravenous delivery of bone marrow cells [J].
Akiyama, Y ;
Radtke, C ;
Honmou, O ;
Kocsis, JD .
GLIA, 2002, 39 (03) :229-236
[3]  
Akiyama Y, 2002, J NEUROSCI, V22, P6623
[4]   Activation of complement pathways after contusion-induced spinal cord injury [J].
Anderson, AJ ;
Robert, S ;
Huang, WC ;
Young, W ;
Cotman, CW .
JOURNAL OF NEUROTRAUMA, 2004, 21 (12) :1831-1846
[5]   Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats [J].
Ankeny, DP ;
McTigue, DM ;
Jakeman, LB .
EXPERIMENTAL NEUROLOGY, 2004, 190 (01) :17-31
[6]  
[Anonymous], INF PAT CLIN TRIAL D
[7]   EMBRYONIC STEM-CELLS EXPRESS NEURONAL PROPERTIES IN-VITRO [J].
BAIN, G ;
KITCHENS, D ;
YAO, M ;
HUETTNER, JE ;
GOTTLIEB, DI .
DEVELOPMENTAL BIOLOGY, 1995, 168 (02) :342-357
[8]   Introducing Transcription Factors to Multipotent Mesenchymal Stem Cells: Making Transdifferentiation Possible [J].
Barzilay, Ran ;
Melamed, Eldad ;
Offen, Daniel .
STEM CELLS, 2009, 27 (10) :2509-2515
[9]   The tumorigenicity of human embryonic and induced pluripotent stem cells [J].
Ben-David, Uri ;
Benvenisty, Nissim .
NATURE REVIEWS CANCER, 2011, 11 (04) :268-277
[10]   Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis [J].
Ben-Hur, T ;
Einstein, O ;
Mizrachi-Kol, R ;
Ben-Menachem, O ;
Reinhartz, E ;
Karussis, D ;
Abramsky, O .
GLIA, 2003, 41 (01) :73-80